Catch it young : Efforts to improve early diagnosis of cancer in India

Here's a proactive measure to address a big problem in cancer treatment in India - cancer detected too late to be cured.  The ministry of health is collaborating with PromOTE India, a non-profit initiative, to take practical oncology training and education to hundreds of medical colleges all over the country. The idea is to train …

Advertisement

India’s drug regulatory regime sucks. What now?

Not one person who has any claim to familiarity with India's pharmaceuticals landscape can pretend to be surprised by the findings of a recent report on the functioning of CDSCO - India's equivalent of the US FDA. However, the report performs a very important task which is putting together recent facts and evidence in the …

It takes a village : What Ranbaxy’s Synriam tells us

Synriam, Ranbaxy's new anti-malarial drug combination, is the first new drug R&D project by an Indian generics company that's yielded a marketable drug. That's big in itself as various media reports have acknowledged. To me, its key value lies not so much in its  "firstness."  Its value is even greater as a case study - …